RONNIE HOELKER: Open Payments
NPI 1811319908 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 41 payments from 13 companies in 2025. Trend: 2023 $204 · 2024 $659 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $156 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $143 |
| Madrigal Pharmaceuticals | 5 | $95 |
| Janssen Biotech, Inc. | 4 | $90 |
| Lilly USA, LLC | 2 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Phathom Pharmaceuticals, Inc. | 3 | $45 |
| GENZYME CORPORATION | 2 | $45 |
| Intercept Pharmaceuticals, Inc. | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: ENTYVIO, RINVOQ, REZDIFFRA, DUPIXENT, TREMFYA, OMVOH, VOQUEZNA, LINZESS.
Industry payments across FL — which companies pay providers there.
